CURASPAN HEALTH GROUP, INC. – Trademark Portfolio
Entity Type: 03
CURASPAN HEALTH GROUP, INC. holds 27 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 25 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include CURASPAN and CURASPAN HEALTH GROUP. The owner is based in NEWTON, MA.
275 GROVE STREET, SUITE 1-110,
RIVERSIDE, CENTER
NEWTON, MA 02466
Showing of trademarks Trademarks
Trademark Classifications
CURASPAN HEALTH GROUP, INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does CURASPAN HEALTH GROUP, INC. have?
CURASPAN HEALTH GROUP, INC. has 27 U.S. trademarks filed with the USPTO. Of these, 3 registered, 8 abandoned, 16 cancelled.
What trademark classes does CURASPAN HEALTH GROUP, INC. file in?
CURASPAN HEALTH GROUP, INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 9 (Computers & Electronics). Class 42 covers scientific and technological services; industrial analysis and research services.
What are CURASPAN HEALTH GROUP, INC.'s most well-known trademarks?
CURASPAN HEALTH GROUP, INC.'s registered trademark portfolio includes well-known marks such as CURASPAN and CURASPAN HEALTH GROUP. These are among 3 currently registered trademarks in the portfolio.
What is CURASPAN HEALTH GROUP, INC.'s trademark registration success rate?
CURASPAN HEALTH GROUP, INC. has a 11% trademark registration rate, with 3 out of 27 resolved applications resulting in successful registration. Currently, 0 applications are pending review.